Editor’s Note Archive

If generic companies are constantly in the news for gross violations of manufacturing norms, their MNC counterparts share the…

Stringent regulations and ever increasing approval timelines are hampering the India pharma story, though recent recommendations…

Bilateral economics and border security issues top the agenda of any India-US strategic dialogue and the recent negotiations…

Dinesh Thakur's expose on Ranbaxy is not the first in the history of the pharmaceutical industry nor will it be the last

Ever since it was first celebrated in 1973, UNEP has used World Environment Day (June 5) to create awareness around…

Clinical research in India seems destined to be in the limelight for the wrong reasons

A fortnight after the Supreme Court of India delivered its judgment in the Novartis/ Glivec case

The world had barely digested and dissected the Supreme Court (SC) verdict on Novartis' Glivec when Glenmark fired another salvo…

In early March, BDR Pharmaceuticals International, a Mumbai-based company dealing in generic APIs and formulations, became the…

From the time of its discovery in 1882 by Robert Koch, to the first World TB Day a century later, the tubercle bacillus has…